Alkem Laboratories to incorporate subsidiary company in Kingdom of Saudi Arabia

12 Aug 2025 Evaluate

Alkem Laboratories has, pursuant to a shareholders’ agreement dated August 12, 2025, has planned to incorporate a subsidiary company (Subsidiary) in the Kingdom of Saudi Arabia. Pursuant to incorporation of such subsidiary, the company will hold 51% of the total share capital. The balance stake of 49% will be held by Abdulaziz Alsheikh (Saudi Partner).

The proposed investment in the Subsidiary is a strategic investment undertaken by the company with the objective of expanding the company’s business and market reach to the Kingdom of Saudi Arabia. The Subsidiary is proposed to be incorporated as a limited liability company and will be involved in the manufacture, import, marketing and distribution of pharmaceutical and/or nutraceutical products within the Kingdom of Saudi Arabia.  

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.


Alkem Laboratories Share Price

5689.30 77.65 (1.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×